Research Catalog

Follow-on biologics : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007.

Title
Follow-on biologics : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007.
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
Publication
Washington : U.S. G.P.O., 2008.

Available Online

  • Text version:
  • PDF version:

Details

Description
1 electronic text (iv, 78 pages) : HTML, digital, PDF file.
Series Statement
  • S. hrg. ; 110-375
  • United States. Congress. Senate. S. hrg. ; 110-375.
Subject
  • Pharmaceutical biotechnology > Government policy > United States
  • Pharmaceutical biotechnology > United States > Patents
  • Pharmaceutical technology > Government policy > United States
  • Drug development > Government policy > United States
Note
  • Title from title screen (viewed on Nov. 17, 2008).
  • Paper version available for sale by the Supt. of Docs., U.S. G.P.O.
Bibliography (note)
  • Includes bibliographical references.
System Details (note)
  • Mode of access: Internet from the GPO Access web site. Addresses as of 11/17/08: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=110%5Fsenate%5Fhearings&docid=f:34053.wais (text version); http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=110%5Fsenate%5Fhearings&docid=f:34053.pdf (PDF version); current access is available via PURLs.
Call Number
GPO Internet Y 4.L 11/4:S.HRG.110-375
OCLC
marcive272396761
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
Title
Follow-on biologics : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007.
Publisher
Washington : U.S. G.P.O., 2008.
Type of Content
text
Type of Medium
computer
Type of Carrier
online resource
Series
S. hrg. ; 110-375
United States. Congress. Senate. S. hrg. ; 110-375.
System Details
Mode of access: Internet from the GPO Access web site. Addresses as of 11/17/08: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=110%5Fsenate%5Fhearings&docid=f:34053.wais (text version); http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=110%5Fsenate%5Fhearings&docid=f:34053.pdf (PDF version); current access is available via PURLs.
Bibliography
Includes bibliographical references.
Connect to:
Text version:
PDF version:
Other Form:
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Follow-on biologics iv, 78 p. (OCoLC)272403831
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Follow-on biologics iv, 78 p. (OCoLC)464618706
Gpo Item No.
1043-C (online)
Sudoc No.
Y 4.L 11/4:S.HRG.110-375
View in Legacy Catalog